Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT03382704

Vellus Hair Loss as a Marker for Peri-ocular Malignancy

Status
Withdrawn
Phase
Study type
Observational
Enrollment
0 (actual)
Sponsor
NHS Lothian · Other Government
Sex
All
Age
18 Years
Healthy volunteers
Not accepted

Summary

Skin cancers around the eye are common, but so are other lid lumps. It is useful to be able to tell which lumps are likely to be cancer. This study looks at whether the loss of fine hairs (vellus hairs) on the skin are a good indicator of whether a lump is a skin cancer or not. The investigators are recruiting patients who have lid lumps who haven't had a biopsy before, who would be having a biopsy as part of their treatment, and seeing whether those who have loss of the fine skin hairs are the same as those who have skin cancer confirmed on their biopsy. The study doesn't involve any extra examinations or treatments for participants. The investigators look at the patients before the biopsy as part of their usual care, and take a note of whether or not they have lost the fine hairs at this stage. The main benefit of participating is that the medical community has better evidence about which lid lumps are likely to represent skin cancer, helping future diagnosis. There are no additional risks to participating. The risks of biopsy are unchanged whether patients participate in the study or not. The study is run from the Princess Alexandra Eye Pavilion in Edinburgh. The investigators aim to start the study in Spring 2020, and will most likely recruit for 6 months depending on the number of participants recruited. There is no additional funding from any source at present - the work will be undertaken by doctors in their research time.

Conditions

Interventions

TypeNameDescription
DIAGNOSTIC_TESTExamination for presence or absence of vellus hairsPre-operative examination for presence or absence of vellus hairs

Timeline

Start date
2020-03-01
Primary completion
2020-09-01
Completion
2020-12-01
First posted
2017-12-26
Last updated
2026-01-16

Locations

1 site across 1 country: United Kingdom

Source: ClinicalTrials.gov record NCT03382704. Inclusion in this directory is not an endorsement.